Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance

Ron T. Varghese, Chiara Dalla Man, Marcello C. Laurenti, Francesca Piccinini, Anu Sharma, Meera Shah, Kent R Bailey, Robert A. Rizza, Claudio Cobelli, Adrian Vella

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims: To compare the performance of population-based kinetics with that of directly measured C-peptide kinetics when used to calculate β-cell responsivity indices, and to study people with and without acute insulin resistance to ensure that population-based kinetics apply to all conditions where β-cell function is measured. Methods: Somatostatin was used to inhibit endogenous insulin secretion in 56 people without diabetes. Subsequently, a C-peptide bolus was administered and the changing concentrations were used to calculate individual kinetic measures of C-peptide clearance. In addition, the participants were studied on 2 occasions in random order using an oral glucose tolerance test (OGTT). On one occasion, free fatty acid elevation, to cause insulin resistance, was achieved by infusion of Intralipid + heparin. The Disposition Index (DI) was then estimated by the oral minimal model using either population-based or individual C-peptide kinetics. Results: There were marked differences in the exchange variables (k12 and k21) of the model describing C-peptide kinetics, but smaller differences in the fractional clearance; that is, the irreversible loss from the accessible compartment (k01), obtained from population-based estimates compared with experimental measurement. Because it is predominantly influenced by k01, DI estimated using individual kinetics correlated well with DI estimated using population-based kinetics. Conclusions: These data support the use of population-based measures of C-peptide kinetics to estimate β-cell function during an OGTT.

Original languageEnglish (US)
Pages (from-to)549-555
Number of pages7
JournalDiabetes, Obesity and Metabolism
Volume20
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

C-Peptide
Insulin Resistance
Population
Glucose Tolerance Test
Somatostatin
Nonesterified Fatty Acids
Heparin
Insulin

Keywords

  • acute insulin resistance
  • C-peptide fractional clearance
  • hepatic insulin extraction
  • insulin action
  • insulin secretion
  • β-cell function

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance. / Varghese, Ron T.; Dalla Man, Chiara; Laurenti, Marcello C.; Piccinini, Francesca; Sharma, Anu; Shah, Meera; Bailey, Kent R; Rizza, Robert A.; Cobelli, Claudio; Vella, Adrian.

In: Diabetes, Obesity and Metabolism, Vol. 20, No. 3, 01.03.2018, p. 549-555.

Research output: Contribution to journalArticle

Varghese, Ron T. ; Dalla Man, Chiara ; Laurenti, Marcello C. ; Piccinini, Francesca ; Sharma, Anu ; Shah, Meera ; Bailey, Kent R ; Rizza, Robert A. ; Cobelli, Claudio ; Vella, Adrian. / Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance. In: Diabetes, Obesity and Metabolism. 2018 ; Vol. 20, No. 3. pp. 549-555.
@article{4d3142a59052470cb7b5e8c87176fa7f,
title = "Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance",
abstract = "Aims: To compare the performance of population-based kinetics with that of directly measured C-peptide kinetics when used to calculate β-cell responsivity indices, and to study people with and without acute insulin resistance to ensure that population-based kinetics apply to all conditions where β-cell function is measured. Methods: Somatostatin was used to inhibit endogenous insulin secretion in 56 people without diabetes. Subsequently, a C-peptide bolus was administered and the changing concentrations were used to calculate individual kinetic measures of C-peptide clearance. In addition, the participants were studied on 2 occasions in random order using an oral glucose tolerance test (OGTT). On one occasion, free fatty acid elevation, to cause insulin resistance, was achieved by infusion of Intralipid + heparin. The Disposition Index (DI) was then estimated by the oral minimal model using either population-based or individual C-peptide kinetics. Results: There were marked differences in the exchange variables (k12 and k21) of the model describing C-peptide kinetics, but smaller differences in the fractional clearance; that is, the irreversible loss from the accessible compartment (k01), obtained from population-based estimates compared with experimental measurement. Because it is predominantly influenced by k01, DI estimated using individual kinetics correlated well with DI estimated using population-based kinetics. Conclusions: These data support the use of population-based measures of C-peptide kinetics to estimate β-cell function during an OGTT.",
keywords = "acute insulin resistance, C-peptide fractional clearance, hepatic insulin extraction, insulin action, insulin secretion, β-cell function",
author = "Varghese, {Ron T.} and {Dalla Man}, Chiara and Laurenti, {Marcello C.} and Francesca Piccinini and Anu Sharma and Meera Shah and Bailey, {Kent R} and Rizza, {Robert A.} and Claudio Cobelli and Adrian Vella",
year = "2018",
month = "3",
day = "1",
doi = "10.1111/dom.13106",
language = "English (US)",
volume = "20",
pages = "549--555",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance

AU - Varghese, Ron T.

AU - Dalla Man, Chiara

AU - Laurenti, Marcello C.

AU - Piccinini, Francesca

AU - Sharma, Anu

AU - Shah, Meera

AU - Bailey, Kent R

AU - Rizza, Robert A.

AU - Cobelli, Claudio

AU - Vella, Adrian

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Aims: To compare the performance of population-based kinetics with that of directly measured C-peptide kinetics when used to calculate β-cell responsivity indices, and to study people with and without acute insulin resistance to ensure that population-based kinetics apply to all conditions where β-cell function is measured. Methods: Somatostatin was used to inhibit endogenous insulin secretion in 56 people without diabetes. Subsequently, a C-peptide bolus was administered and the changing concentrations were used to calculate individual kinetic measures of C-peptide clearance. In addition, the participants were studied on 2 occasions in random order using an oral glucose tolerance test (OGTT). On one occasion, free fatty acid elevation, to cause insulin resistance, was achieved by infusion of Intralipid + heparin. The Disposition Index (DI) was then estimated by the oral minimal model using either population-based or individual C-peptide kinetics. Results: There were marked differences in the exchange variables (k12 and k21) of the model describing C-peptide kinetics, but smaller differences in the fractional clearance; that is, the irreversible loss from the accessible compartment (k01), obtained from population-based estimates compared with experimental measurement. Because it is predominantly influenced by k01, DI estimated using individual kinetics correlated well with DI estimated using population-based kinetics. Conclusions: These data support the use of population-based measures of C-peptide kinetics to estimate β-cell function during an OGTT.

AB - Aims: To compare the performance of population-based kinetics with that of directly measured C-peptide kinetics when used to calculate β-cell responsivity indices, and to study people with and without acute insulin resistance to ensure that population-based kinetics apply to all conditions where β-cell function is measured. Methods: Somatostatin was used to inhibit endogenous insulin secretion in 56 people without diabetes. Subsequently, a C-peptide bolus was administered and the changing concentrations were used to calculate individual kinetic measures of C-peptide clearance. In addition, the participants were studied on 2 occasions in random order using an oral glucose tolerance test (OGTT). On one occasion, free fatty acid elevation, to cause insulin resistance, was achieved by infusion of Intralipid + heparin. The Disposition Index (DI) was then estimated by the oral minimal model using either population-based or individual C-peptide kinetics. Results: There were marked differences in the exchange variables (k12 and k21) of the model describing C-peptide kinetics, but smaller differences in the fractional clearance; that is, the irreversible loss from the accessible compartment (k01), obtained from population-based estimates compared with experimental measurement. Because it is predominantly influenced by k01, DI estimated using individual kinetics correlated well with DI estimated using population-based kinetics. Conclusions: These data support the use of population-based measures of C-peptide kinetics to estimate β-cell function during an OGTT.

KW - acute insulin resistance

KW - C-peptide fractional clearance

KW - hepatic insulin extraction

KW - insulin action

KW - insulin secretion

KW - β-cell function

UR - http://www.scopus.com/inward/record.url?scp=85042100435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042100435&partnerID=8YFLogxK

U2 - 10.1111/dom.13106

DO - 10.1111/dom.13106

M3 - Article

VL - 20

SP - 549

EP - 555

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 3

ER -